During the week there had been some news articles about Turing Pharmaceuticals and its CEO, Martin Shkreli, jacking up the price of a drug that has been around for at least 60 years, from $13.50 to $750 a pill. The stated reason for doing so: “needed to make a profit”.
Um how about: price gouging because they can (or think they can – they’ve since reduced it).
Fortunately, there has been a lot of hullabaloo surrounding such price increase that even Hillary Clinton chimed in, calling for controls over drug price increases.
The bad boy, Martin Shkreli, was a former hedge fund manager. Ahhh, now things become clearer. He’s the new poster boy for bad behavior from these financial types.